V ascular injury induces a variety of pathological consequences such as loss of endothelia, followed by thrombus formation, and neointimal thickening.
V ascular injury induces a variety of pathological consequences such as loss of endothelia, followed by thrombus formation, and neointimal thickening. [1] [2] [3] Thus, reendothelialization is an important therapeutic strategy for achieving vascular repair in subjects with coronary artery disease undergoing mechanical revascularization. We and others have previously shown that in vivo administration of endothelial progenitor cells (EPCs) can induce both reparative angiogenesis and reendothelialization. [4] [5] [6] Induced pluripotent stem (iPS) cells were first generated from mouse skin fibroblasts by introducing 4 transcriptional factors. 7 iPS cells can differentiate into various cell types, including endothelial cells and vascular smooth muscle cells, and vascular endothelial growth factor receptor fetal liver kinase-1-positive (Flk-1 + ) cells can give rise to vascular wall cells. 8, 9 Thus, iPS cell-derived Flk-1 + cells are called vascular progenitor cells that can supply EPCs. Recently, we demonstrated that transplantation of iPS cellderived Flk-1 + cells enhanced ischemia-induced angiogenesis in vivo. 10, 11 However, the therapeutic efficacy of iPS cells for reendothelialization and prevention of neointimal formation has not been examined. Accordingly, we investigated the effects of intravenously transfused iPS cell-derived Flk-1 + cells on reendothelialization and neointimal formation using a well-established mouse model of vascular injury.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Mouse Model of Vascular Injury
Male KSN athymic nude mice were obtained from SLC Co Ltd (Nagoya, Japan). Study protocols were approved by the Institutional Animal Care and Use Committee of Nagoya University. Eight-weekold mice were subjected to arterial wire injury as previously described. 12 Briefly, the left femoral arteries of these mice were injured using a 0. Because reendothelialization after vascular injury plays an important role in the prevention of neointimal thickening, 3 we assessed the extent of endothelial repair in injured arteries on postoperative day 7 by means of Evans blue staining. Figure 1C ). Quantitative analysis of the areas stained and not stained with Evans blue dye revealed that iPS cellderived Flk-1 + treatment significantly accelerated reendothelialization of the injured arteries, as compared with iPS cell-derived Flk-1 − treatment and the control ( Figure 1D ). Furthermore, we analyzed the extent of reendothelialization by staining for the endothelial cell marker CD31 in arterial lumen at day 7 after injury ( Figure 1E ). Quantitative analysis of CD31 + cells in the lumen of injured vessels revealed reendothelialization was significantly enhanced by iPS cellderived Flk-1 + treatment compared with iPS cell-derived Flk-1 − treatment and the control ( Figure 1E ).
CXCR4 Expression in iPS Cell-Derived Flk-1 + Cells Contributes to Adhesion and Migration Activities
To test whether transfused iPS cell-derived Flk-1 + cells contribute to reendothelialization, PKH26-labeled iPS cellderived Flk-1 + or Flk-1 − cells were injected into the jugular vein 1 day after vascular injury. Immunohistochemical analysis revealed PKH26-labeled iPS cell-derived Flk-1 + cells at the site of endothelial injury, lining the intraluminal margin of the neointima at day 7 after vascular injury (Figure 2A ). In contrast, few iPS cell-derived Flk-1 − cells were detectable in the injured vessels. These cells likewise were not observed in the uninjured parts or the contralateral vessel. We also examined whether in vivo transfused iPS cell-derived Flk-1 To further investigate the relevance of CXCR4 surface expression in the homing of iPS cell-derived Flk-1+ cells, we performed an adhesion assay. Basal adhesion capacity did not differ between iPS cell-derived Flk-1 + and Flk-1 − cells. The adhesion capacity of iPS cell-derived Flk-1 + cells was dramatically increased by stimulation with the CXCR4 ligand, stromal cell-derived factor (SDF)-1α, whereas SDF-1α stimulation had no effect in the adhesion capacity of iPS cell-derived Flk-1 − cells ( Figure 2D ). The SDF-1α-induced adhesion activity of iPS cell-derived Flk-1 + cells was blocked by preincubation with an anti-CXCR4 neutralizing antibody ( Figure 2D ). In addition, we confirmed that SDF-1α is expressed in media and neointima at day 7 after vascular injury in vivo as previously described ( Figure III in the onlineonly Data Supplement). 13, 14 Finally, we investigated the migration capacity of iPS cellderived Flk-1 + cells in response to SDF-1α in a transwell migration assay. The numbers of spontaneous migrations did not differ between iPS cell-derived Flk-1 + and Flk-1 − cells. However, iPS cell-derived Flk-1 + cells showed an increased response to the SDF-1α-mediated chemotactic effect as compared with iPS cell-derived Flk-1 − cells ( Figure 2E ). Preincubation with anti-CXCR4 neutralizing antibody diminished the SDF-1α-mediated migration of iPS cell-derived Flk-1 + cells ( Figure 2E ).
Discussion
The present study provides the first evidence that iPS cellderived Flk-1 + cells, or iPS cell-derived vascular progenitor cells, function to prevent the neointimal thickening after arterial injury. Intravenously transfused iPS cell-derived Flk-1 + cells enhanced reendothelialization associated with decreased neointimal hyperplasia in mechanically injured arteries in vivo.
We recently showed that direct local implantation of mouse iPS cell-derived Flk-1 + cells enhanced ischemia-induced angiogenesis in a mouse model of hindlimb ischemia. 10, 11 Implanted Flk-1 + cells derived from mouse iPS cells differentiated into endothelial cells in the chronic phase. 10 Intramyocardial transplantation of iPS cell-derived Flk-1 + cells also stimulated angiogenesis and improved cardiac function after myocardial infarction in mice. 15 In the present study, intravenously transfused iPS cell-derived Flk-1 + cells were recruited to the site of vascular injury in mice, resulting in enhanced reendothelialization associated with decreased neointimal hyperplasia. Thus, the sorting of iPS cells using the cell surface marker, Flk-1, is a potentially useful strategy for vascular regenerative medicine, including angiogenesis and reendothelialization.
Previous studies demonstrated that CXCR4 in EPCs is essential for their recruitment and homing. 13 Blockade of CXCR4 function attenuated EPC recruitment to injured arteries. 16 In contrast, adenovirus-mediated overexpression of CXCR4 improved the functional properties of EPCs and enhanced reendothelialization in the injured artery. 17 The ligand of CXCR4, SDF-1α, is expressed in injured arteries with a marked mobilization of EPCs in peripheral blood, resulting in cell homing to the site of reendothelialization. 13 Treatment with an anti-SDF-1α-neutralizing antibody delayed reendothelialization of injured arteries. 13 In the present study, we demonstrated that iPS cell-derived Flk-1 + cells express high levels of CXCR4, whereas iPS cell-derived Flk-1 − cells do not. Recruitment of transfused iPS cell-derived Flk-1 + cells to the injured artery was confirmed in vivo. Furthermore, iPS cell-derived Flk-1 + cells exhibited more substantial adhesion and migration activities compared with iPS cell-derived Flk-1 − cells in vitro. Collectively, these results indicate that the SDF-1α/CXCR4 axis might be crucial for homing of iPS cell-derived Flk-1 + cells after endothelial injury to induce reendothelialization and to limit neointimal hyperplasia.
In the context of possible iPS cell therapies, coating of polymer stents or systemic vascular grafts with iPS cellderived Flk-1 + cells may support endothelialization, thereby effectively preventing postangioplasty restenosis and obstructive neointimal graft insufficiency. Thus, iPS cell-derived Flk-1 + cells are a potentially valuable resource for vascular disease treatment in the future.
